Les Laboratoires Servier has filed a patent for anti-CD73 antibodies and their use in treating diseases related to CD73 activity, such as cancer. The patent claims specific amino acid sequences for the antibodies and their binding to human CD73. GlobalData’s report on Les Laboratoires Servier gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Les Laboratoires Servier, Cancer treatment biomarkers was a key innovation area identified from patents. Les Laboratoires Servier's grant share as of September 2023 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Anti-cd73 antibodies for treating diseases, especially cancer
A recently filed patent (Publication Number: US20230227573A1) describes an anti-CD73 antibody or antigen-binding portion that binds to the same epitope of human CD73 as specific antibodies. The patent claims various combinations of amino acid sequences for the heavy chain (HC) and light chain (LC) of the antibody. Additionally, the patent claims that the antibody or antigen-binding portion can have specific properties, such as inhibiting CD73 activity, binding to CD73 with high affinity, and inhibiting tumor growth in vivo.
The patent claims cover a range of anti-CD73 antibodies or antigen-binding portions that bind to the same epitope of human CD73 as specific antibodies. The antibodies are described by their amino acid sequences for the heavy chain and light chain. The patent also claims that the antibodies or antigen-binding portions can have various properties, including inhibiting CD73 activity, binding to CD73 with high affinity, and inhibiting tumor growth in vivo.
These claims suggest that the disclosed anti-CD73 antibodies or antigen-binding portions have potential therapeutic applications
To know more about GlobalData’s detailed insights on Les Laboratoires Servier, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
